Mis-Selling in Life Insurance Is Rising: 5 Red Flags to Watch Before Signing Any Policy
Mis-Selling in Life Insurance Is Rising: 5 Red Flags to Watch Before Signing Any Policy
IRDAI’s FY25 annual report flags mis-selling as an “alarming” problem. Over 26,667 unfair-practice complaints were filed last year alone. Here’s what every Indian policyholder must know before putting pen to paper.
Why Mis-Selling Is a Crisis You Cannot Ignore
Walk into any bank branch to open an FD, and there’s a reasonable chance a relationship manager will slide a life insurance brochure across the desk before you leave. It might be framed as a “guaranteed return scheme,” a “tax-free investment,” or a “pension with life cover.” Rarely will they lead with the word “insurance.” This is the heart of the mis-selling epidemic gripping India’s life insurance sector.
The numbers are striking. IRDAI’s Annual Report 2024-25 shows that while total life insurance complaints have remained largely stable at approximately 1,20,429, the proportion classified as Unfair Business Practices (UBP) — the regulatory category that covers mis-selling — has climbed sharply, from 19.33% in FY24 to 22.14% in FY25. In absolute terms, that means 26,667 formal complaints about how policies were sold, explained, and serviced.
IRDAI Member Satyajit Tripathy left no room for ambiguity at the CII Financial Summit in Mumbai: “Grouse in life insurance is about mis-selling a product and I must say that it is at an alarming level.” Policy-makers, not just consumer activists, have officially sounded the alarm.
“Mis-selling in the Indian insurance sector is a significant concern that involves the sale of insurance products to consumers without proper disclosure of terms, conditions, or suitability.”
— IRDAI Annual Report 2024-25But data only tells part of the story. The real damage is personal and financial. Research cited by Insurance Samadhan found that 43.3% of all benefits paid by the top 10 life insurers relate to surrendered, withdrawn, discontinued, or lapsed policies — meaning nearly half of Indian policyholders walk away from policies before they can fulfil their purpose. A customer who surrenders a policy in year two can expect to recover as little as 30% of premiums paid, per IRDAI-defined surrender value rules.
The 61-month persistency ratio — a key metric measuring how many policies stay active for five years — sits at a dismal 51%. In a country where insurance penetration languishes at just 3.7% of GDP against the global average of 7.3%, the systemic damage of mis-selling is significant: it creates mistrust, forces premature exits, and denies millions of Indians the financial protection they thought they were paying for.
To protect yourself and your family, you need to know what mis-selling actually looks like on the ground. Below are the five most common and most dangerous red flags — drawn from IRDAI data, ombudsman case analyses, and 15 years of observing how Indian financial distribution actually works.
The 5 Red Flags of Life Insurance Mis-Selling
The Policy Is Described as an “Investment” or “Savings Plan” — Not Insurance
This is perhaps the oldest trick in the mis-selling playbook. A bancassurance executive or agent positions a Unit Linked Insurance Plan (ULIP) or endowment policy as a “tax-saving investment with life cover” rather than as a life insurance product with an investment component. The word “insurance” may never even appear in the sales pitch.
Why it matters: ULIP charges — including premium allocation charges, fund management fees, policy administration charges, and mortality charges — can collectively erode 20-40% of your first-year premium in older product structures. When pitched as a pure investment, these costs are often not disclosed upfront. The buyer, expecting FD-like returns, is blindsided when surrendering early.
According to Insurance Samadhan’s Q2 2025 Trends Report, endowment policies are the single most mis-sold category of life insurance product, with complaints up 11.2% over the same period in 2024.
Returns Are Stated as “Guaranteed” Without Showing the Benefit Illustration
One of the most persistent forms of mis-selling involves agents quoting specific return figures — “you’ll get ₹25 lakhs after 20 years” — without presenting the mandatory Benefit Illustration document that shows returns at the standardised 4% and 8% scenarios mandated by IRDAI.
Verbal promises are legally unenforceable. Yet survey data from 1 Finance across 20 banks in 15 cities found that 57% of relationship managers admitted they had been instructed to sell financial products regardless of suitability. In that pressure-driven environment, optimistic verbal projections are common tools to close sales fast.
For traditional endowment and money-back plans, the actual Internal Rate of Return (IRR) is typically in the range of 4%–5.5% — far below what equity mutual funds or even tax-free bonds have historically returned. Yet these products are routinely sold as superior alternatives to PPF or NPS.
You Are Rushed Through the Application — No Suitability Discussion
IRDAI’s regulations require insurers and intermediaries to conduct a suitability assessment before recommending a product — this means understanding your age, income, existing coverage, financial goals, and risk appetite. In practice, especially in bancassurance settings, this step is often skipped entirely in the race to meet monthly sales targets.
The structural problem is well-documented: corporate agents — primarily banks — accounted for nearly 53% of private life insurers’ individual new business premium in FY25, with banks alone responsible for more than 49% of such premium. This concentration makes bancassurance the single highest-risk channel for mis-selling, because bank staff face enormous cross-selling pressure and often have only basic insurance training.
If an agent fills in your form, hands you papers to sign quickly, avoids discussing the policy exclusions, or does not ask about your existing insurance coverage, these are serious procedural red flags indicating that a suitability check was never conducted.
The Policy Is Sold as a Replacement for an Existing, Active Policy
Known in insurance regulation as “policy churning” or “twisting,” this practice involves convincing a policyholder to surrender an existing policy and replace it with a new one — primarily to generate fresh commissions for the agent. Because surrender values in the early years of a policy are heavily penalised, the policyholder invariably suffers a financial loss in the transition.
IRDAI rules explicitly prohibit inducing a policyholder to lapse, forfeit, or surrender a policy in favour of a new policy when it is not genuinely in their interest. Yet this violation is hard to detect from a regulator’s perspective unless the policyholder files a complaint — which brings us back to that 26,667 figure of formal grievances, representing only a fraction of actual incidents.
Watch for language like “your old policy is not performing,” “this new product has better features,” or “your previous policy doesn’t have this latest benefit.” These can be legitimate assessments — but they can also be commission-motivated manipulation.
Critical Terms and Exclusions Are Not Disclosed — Or Actively Hidden
IRDAI’s own definition of mis-selling centres on this issue: “the sale of insurance products to consumers without proper disclosure of terms, conditions, or suitability.” Non-disclosure of critical policy terms — waiting periods, exclusions, surrender charges, premium payment duration vs. policy tenure, and the distinction between sum assured and maturity benefit — is at the root of most life insurance complaints.
Common non-disclosed clauses include: limited premium payment terms (you pay for 10 years but the policy runs for 20), auto-debit or ECS mandates that make it hard to stop premiums, lock-in periods during which surrender results in capital loss, and the absence of rider coverage (e.g., critical illness or accidental death riders are separate costs, not automatic inclusions).
In a high-pressure sales environment, agents often avoid mentioning these features because they reduce the appeal of the product. A complaint filed after the free-look period typically yields little remedy: of the mis-selling grievances disposed of in FY25, more than 15,000 were decided against policyholders, while only about 11,400 were resolved in their favour.
Mis-Sold Policy vs. Right Policy: Know the Difference
Not every complex financial product is necessarily wrong for you — but you should be able to clearly see what you are buying and why. Use this comparison to evaluate any policy pitch you receive.
| Factor | Mis-Selling Scenario | Ethical Sale Scenario |
|---|---|---|
| Product Framing | RISK Pitched as “investment” or “savings scheme” | SAFE Clearly described as a life insurance product |
| Returns Promise | RISK Specific rupee amounts promised verbally | SAFE Written Benefit Illustration provided at 4% & 8% |
| Suitability Check | RISK No questions about income, goals, or existing coverage | SAFE Detailed needs analysis conducted and documented |
| Policy Document | RISK Form pre-filled; rushed signatures; no reading time | SAFE Ample time provided; all terms explained clearly |
| Exclusions Discussed? | RISK Only benefits highlighted; exclusions glossed over | SAFE All exclusions, lock-ins, and surrender values disclosed |
| Replacement Pitch | RISK Advised to surrender active policy with no comparison | SAFE Written comparison provided before any recommendation |
| Free-Look Period | RISK Agent discourages reading; downplays return right | SAFE Free-look period clearly communicated, in writing |
🛠️ If You Suspect You’ve Been Mis-Sold a Policy: Step-by-Step Action
- Within free-look period (15–30 days): Return the policy immediately to the insurer. You are entitled to a near-full premium refund (minus proportionate risk premium and medical examination charges).
- Write a formal grievance: File a complaint directly with the insurer’s grievance officer. Reference IRDAI’s Integrated Grievance Management System (IGMS) / Bima Bharosa portal for tracking.
- Escalate to IRDAI: If unresolved within 30 days, escalate via the Bima Bharosa portal (bimabharosa.irdai.gov.in) or call the IRDAI Grievance Call Centre: 1800-4254-732 (toll-free).
- Approach the Insurance Ombudsman: For claims or disputes up to ₹50 lakh, the Ombudsman process is free for policyholders. Contact the office in your jurisdiction.
- Consumer Court (NCDRC / SCDRC): For larger mis-selling losses or if other channels fail, file under the Consumer Protection Act 2019. Courts have increasingly ruled in favour of mis-selling victims.
Why Mis-Selling Persists: The Commission Incentive Problem
Understanding why mis-selling happens makes you better equipped to recognise it. The answer, in most cases, is straightforward: commissions. Research by 1 Finance Magazine found that India’s top 15 banks collectively earned over ₹21,773 crore in commissions in FY24 from selling insurance and other third-party financial products. Relationship managers at banks are often given monthly targets for insurance premium mobilisation — and their salary increments or bonuses may depend on meeting them.
IRDAI’s own data shows that bancassurance partnerships dominate: corporate agents, including bank partners, accounted for nearly 53% of private life insurers’ individual new business premium in FY25. This structural concentration means that the channel most trusted by ordinary Indians — their own bank — is also the channel carrying the highest mis-selling risk.
Until incentive structures are reformed at a systemic level — something IRDAI’s 2024-25 annual report explicitly calls for — individual vigilance remains the only reliable line of defence for policyholders. The regulator has asked insurers to conduct root-cause analysis and implement product-suitability assessments by distribution channel, but these measures are at an early stage.
Your Pre-Signature Checklist: 10 Questions to Ask Every Insurance Agent
- Is this a life insurance product? What is the sum assured (death benefit)?
- Can you show me the mandatory Benefit Illustration at 4% and 8% growth rates?
- What is the total premium I will pay over the policy term?
- What is the surrender value if I exit in Year 2, Year 5, and Year 10?
- What are all the charges deducted? (Mortality, fund management, allocation, admin fees)
- What are the major exclusions and waiting periods under this policy?
- Is the premium-paying term the same as the policy term? If not, explain the difference.
- Has a suitability assessment been conducted and documented for me personally?
- What is my free-look period and how do I exercise it?
- Are the returns you’ve projected guaranteed or market-linked (non-guaranteed)?
